Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure that people who require insulin are able to access it.

We are aware of a supply disruption affecting Tresiba (Insulin degludec) FlexTouch 100 units per millilitre solution for injection three millilitre pre-filled pens. While we do not hold information on number of people affected by this issue, we have worked with industry to identify suitable alternatives and can confirm that Tresiba Penfill cartridges are available and can fully support the increase in demand.

A National Patient Safety Alert was issued for Tresiba Flextouch pens on Friday 8 December 2023, providing updates to the National Health Service about the supply issue and providing advice for healthcare professionals on how to manage patients during the supply disruption. Any patient who is concerned should speak to their clinician.

There is a team within the Department that deals specifically with medicine supply problems. It has well-established tools and processes to manage medicine supply issues, working closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and expedite resupply as soon as possible to ensure that the risks to patients are minimised. Information on the number of people affected by the supply issue is not held.